81 related articles for article (PubMed ID: 1708604)
21. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
Volm M; Drings P; Kleine W; Mattern J
Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
[TBL] [Abstract][Full Text] [Related]
22. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
23. Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions.
Diaz-Cano SJ; de Miguel M; Blanes A; Galera H; Wolfe HJ
Hum Pathol; 2001 Nov; 32(11):1232-9. PubMed ID: 11727263
[TBL] [Abstract][Full Text] [Related]
24. [Diagnostic guidelines for adrenal gland nodules: typing, assessment of biological potential and prognosis, molecular pathogenesis].
Schröder S; Padberg B; Reincke M; Komminoth P
Verh Dtsch Ges Pathol; 1997; 81():97-102. PubMed ID: 9474859
[TBL] [Abstract][Full Text] [Related]
25. Cellular DNA profiles of benign and malignant adrenocortical tumors.
Cibas ES; Medeiros LJ; Weinberg DS; Gelb AB; Weiss LM
Am J Surg Pathol; 1990 Oct; 14(10):948-55. PubMed ID: 2403197
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11.
Schröder S; Niendorf A; Achilles E; Dietel M; Padberg BC; Beisiegel U; Dralle H; Bressel M; Klöppel G
Virchows Arch A Pathol Anat Histopathol; 1990; 417(2):89-96. PubMed ID: 2114700
[TBL] [Abstract][Full Text] [Related]
27. [Pathological and clinical features of malignant thyroid tumors: classification, immunohistology, prognostic criteria].
Schröder S
Veroff Pathol; 1988; 130():1-159. PubMed ID: 3213226
[TBL] [Abstract][Full Text] [Related]
28. High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients.
Saeger W; Fassnacht M; Chita R; Prager G; Nies C; Lorenz K; Bärlehner E; Simon D; Niederle B; Beuschlein F; Allolio B; Reincke M
Hum Pathol; 2003 Feb; 34(2):180-6. PubMed ID: 12612887
[TBL] [Abstract][Full Text] [Related]
29. Studies on pathological morphology, clinical features and nuclear DNA contents by flow cytometry in adrenal neoplasms.
Zhang XH; Wei SL; Wang FR; Wang JL; Xie TX; Liu DW; Zuo LF; Guo JW
Chin Med J (Engl); 1992 Feb; 105(2):139-43. PubMed ID: 1597074
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometric analysis of deoxyribonucleic acid ploidy in benign and malignant aldosterone-producing neoplasms of the adrenal gland.
Rainwater LM; Young WF; Farrow GM; Grant CS; van Heerden JA; Lieber MM
Surg Gynecol Obstet; 1989 Jun; 168(6):491-6. PubMed ID: 2727877
[TBL] [Abstract][Full Text] [Related]
31. [Adrenocortical tumors with neuroendocrine differentiation].
Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
[TBL] [Abstract][Full Text] [Related]
32. DNA quantification and ploidy patterns in human adrenocortical neoplasms.
Pignatelli D; Leitão D; Maia M; Schmidt F
Endocr Res; 1998; 24(3-4):869-74. PubMed ID: 9888590
[TBL] [Abstract][Full Text] [Related]
33. Adrenocortical tumors in children.
Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
[TBL] [Abstract][Full Text] [Related]
34. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
[TBL] [Abstract][Full Text] [Related]
35. The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas.
van't Sant HP; Bouvy ND; Kazemier G; Bonjer HJ; Hop WC; Feelders RA; de Herder WW; de Krijger RR
Histopathology; 2007 Aug; 51(2):239-45. PubMed ID: 17593212
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.
Stojadinovic A; Hoos A; Nissan A; Dudas ME; Cordon-Cardo C; Shaha AR; Brennan MF; Singh B; Ghossein RA
Hum Pathol; 2003 Jan; 34(1):54-64. PubMed ID: 12605367
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
38. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study].
al-Abadi H; Nagel R
Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855
[TBL] [Abstract][Full Text] [Related]
39. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
[TBL] [Abstract][Full Text] [Related]
40. Intratumoral heterogeneity in colorectal carcinoma: trucut sampling for DNA ploidy analysis.
Giovagnoli MR; Giarnieri E; Midiri G; Tesoriere A; Ferraro S; Vecchione A
Anticancer Res; 1999; 19(5C):4577-80. PubMed ID: 10650813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
